期刊文献+

糖基化白蛋白促内皮细胞小管样结构形成及其机制 被引量:3

Effects of advanced glycated bovine serum albumin on tubule like structure formation of endothelial cells and their mechanisms
在线阅读 下载PDF
导出
摘要 目的观察糖基化牛血清白蛋白(advanced glycated bovine serum albumin,AGE-BSA)对人脐静脉血管内皮细胞(human umbilical vein endothelial cells,HUVEC)小管样结构(tubule like structure,TLS)形成的影响并探讨其可能机制。方法实验设实验组、实验对照组和空白对照组。实验组设25、50、100μg/ml3个AGE-BSA浓度;同时设置相同浓度的牛血清白蛋白(bovine serum albumin,BSA)作为实验对照组;内皮细胞完全培养基作为空白对照组。各组设24、48、72h3个时相点,采用三维胶TLS形成实验和ELISA方法分别检测不同浓度AGE-BSA作用下HUVEC在Ⅰ型胶原中形成TLS的长度以及HUVEC自分泌血管内皮细胞生长因子(vascular endothelial growth factor,VEGF)的浓度。结果在24~72h内,浓度为25~100μg/ml的AGE-BSA比相同浓度的BSA使HUVEC培养上清中VEGF的量和在胶原中分化形成TLS的长度均明显增加(P<0.05)。结论AGE-BSA可通过刺激VEGF自分泌促进内皮细胞TLS形成,提示糖基化终末产物可能参与糖尿病视网膜血管生成。 Objective To observe the effects of advanced glycated bovine serum albumin (AGE-BSA) on the tubule like structure (TLS) formation of endothelial cells. Methods There were three groups: AGE-BSA (25, 50 and 100 μg/ml) treated groups, BSA (25, 50 and 100 μg/ml) treated groups as BSA control groups, endothelial complete medium without AGE-BSA or BSA as blank control groups. After incubation of human umbilical vein endothelial cells (HUVECs) for 24, 48 and 72 h, TLS formation assay and ELISA were used to detect the length of TLS formation on the surface of collagen Ⅰ and the vascular endothelial growth factor (VEGF) autocrine of HUVECs in presence of AGE-BSA. Results In 24 to 72 h, AGE-BSA (25, 50, 100 μg/ml) increased the average length of TLS formation on the surface of collagen Ⅰ and the concentration of VEGF autocrine in supernatant of HUVECs (P 〈 0.05 ). Conclusion AGE-BSA drives TLS formation by stimulating VEGF autoerine of HUVECs, suggesting AGEs play an important role in angiogenesis of diabetic retinopathy.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第12期1158-1160,共3页 Journal of Third Military Medical University
基金 国家高技术研究发展计划("863"计划)(2002AA001010)~~
关键词 糖基化终末产物 小管样结构 糖尿病视网膜病变 血管内皮生长因子 advanced glycation end products tubule like structure diabetic retinopathy vascular endothelial growth factor
  • 相关文献

参考文献10

  • 1Staton C A,Stribbling S M,Tazzyman S,et al.Current methods for assaying angiogenesis in vitro and in vivo[J].Int J Exp Pathol,2004,85(5):233-248.
  • 2Jaffe E A,Nachman R L,Becker C G,et al.Culture of human endothelial cells derived from umbilical veins.Identification by morphologic and immunologic criteria[J].J Clin Invest,1973,52(11):2745-2756.
  • 3Ayalasomayajula S P,Kompella U B.Celecoxib,a selective cyclooxygenase-2 inhibitor,inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model[J].Eur J Pharmacol,2003,458 (3):283-289.
  • 4Zhou J,Brune B.NO and transcriptional regulation:from signaling to death[J].Toxicology,2005,208(2):223-233.
  • 5Soro-Paavonen A,Forbes J M.Novel therapeutics for diabetic micro-and macrovascular complications[J].Curr Med Chem,2006,13(15):1777-1788.
  • 6Shoji T,Koyama H,Morioka T,et al.Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes[J].Diabetes,2006,55(8):2245-2255.
  • 7戴超,卞修武,史景泉.诺帝抑制糖尿病大鼠视网膜VEGF和iNOS的表达及意义[J].第三军医大学学报,2005,27(12):1232-1235. 被引量:13
  • 8Yamagishi S,Yonekura H,Yamamoto Y,et al.Advanced glycation end products-driven angiogenesis in vitro.Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor[J].J Biol Chem,1997,272(13):8723-8730.
  • 9Mamputu J C,Renier G.Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products:inhibitory effect of gliclazide[J].Diabetes Obes Metab,2004,6(2):95-103.
  • 10Okamoto T,Tanaka S,Stan A C,et al.Advanced glycation end products induce angiogenesis in vivo[J].Microvasc Res,2002,63(2):186-195.

二级参考文献10

  • 1Takagi H, Oh H, Otani A, et al. Molecular mechanisms of retinal neovascularization in diabetic retinopathy [ J ]. International Congress Series,2004,1262: 160 - 163.
  • 2Cukiernik M, Hileeto D, Evans T, et al. Vascular endothelial growth factor in diabetes induced early retinal abnormalities [J]. Diabetes Res Clin Prac,2004,65(3) : 197 - 208.
  • 3Scatia A, Pechan P, Lukason M, et al. Inhibition of retinal neovascularization by intraocular gene delivery of soluble VEGF receptors [ J ]. Mol Ther, 2004,9(Suppl 1) :S198.
  • 4Marano R J, Wimmer N, Kearns P S, et al. Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide[J]. Exp Eye Res, 2004,79(4) : 525 - 535.
  • 5Berkowitz B A, Luan H, Gupta R R, et al. Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase[J]. Diabetes, 2004,53(1): 173 - 178.
  • 6Cukiernik M, Hileeto D, Downey D, et al. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina[J]. Diabetes Metab Res Rev, 2004,20(1): 61 - 71.
  • 7Ayalasomayajula S P, Kompella U B. Celecoxib, a selective cyclooxygenase - 2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin - induced diabetic rat model[J].Eur J Pharmcol, 2003,458 (3) : 283 - 289.
  • 8Takeda M, Mori F, Yoshida A, et al. Constitutive nitric oxide synthase is associated with retinal vascular peimeability in early diabetic mrs[J]. Diabetologia, 2001,44(8) : 1043 - 1050.
  • 9Rota R, Chiavaroli C, Garay R P, et al. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin - diabetic rats [J]. Eur J Pharmacol, 2004, 495(2) : 217 - 224.
  • 10孙慧勤,陈意生,史景泉,卞修武,邹仲敏,郭德玉,辛榕.去甲二氢愈创木酸对VEGF及其受体KDR基因表达影响的研究[J].第三军医大学学报,2001,23(3):268-271. 被引量:4

共引文献12

同被引文献20

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部